Skip to main content
大唐药业 logo

大唐药业 — Investor Relations & Filings

Ticker · 920433 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 420 across all filing types
Latest filing 2025-08-26 Governance Information
Country CN China
Listing Beijing Stock Exchange 920433

About 大唐药业

http://www.nmdt.com.cn/

Inner Mongolia Datang Pharmaceutical specializes in the research, development, and production of traditional Chinese and Mongolian medicines. The company focuses on modernizing ethnic medicinal formulas through advanced biotechnology and standardized manufacturing processes. Its product portfolio covers therapeutic areas including respiratory health, cardiovascular conditions, and gastrointestinal disorders. Notable offerings include Xuanfei Zhike granules and specialized Mongolian medicinal preparations. The organization integrates traditional knowledge with contemporary clinical research to develop proprietary formulations. By maintaining rigorous quality management systems and investing in automated production lines, the company aims to enhance the efficacy and accessibility of ethnic medicines for a broad patient base.

Recent filings

Filing Released Lang Actions
关联交易管理制度
Governance Information Classification · 95% confidence The document is titled as "关联交易管理制度" which translates to "Related Party Transaction Management System". It is a detailed internal management system document regarding related party transactions, including definitions, procedures, disclosure requirements, and approval processes. The document includes references to company laws, securities laws, and stock exchange regulations, and it is approved by the company's board and requires shareholder approval. It is not a financial report, earnings release, or announcement of voting results. It is a governance-related document detailing internal rules and procedures for managing related party transactions. Therefore, it fits best under Governance Information (CGR). The document length is 6893 characters, indicating it is a full document, not a brief announcement or certification.
2025-08-26 Chinese
股东会议事规则
Governance Information Classification · 95% confidence The document is titled as the "Shareholders Meeting Rules" of Inner Mongolia Datang Pharmaceutical Co., Ltd. It details the procedures, rights, and regulations governing the company's shareholders meetings, including the convening, proposal submission, voting, and resolutions. It is a governance document outlining internal rules and procedures rather than a report of financial results, voting outcomes, or announcements. It does not contain financial statements or earnings data, nor is it an announcement of a meeting or voting results. The content aligns with governance practices and internal company rules for shareholder meetings, which fits the definition of Governance Information (CGR). The document length is substantial and contains detailed governance rules, not a brief announcement or a report publication notice.
2025-08-26 Chinese
累积投票实施细则
Governance Information Classification · 100% confidence The document is titled as the "Implementation Rules for Cumulative Voting System" by the board of Inner Mongolia Datang Pharmaceutical Co., Ltd. It details the procedures and rules for electing directors using cumulative voting, including nomination, voting, and election results. The document includes board meeting dates and voting results on the adoption of these rules. It is a governance-related document focused on internal company rules and board election procedures. There is no financial data, no audit or earnings information, no shareholder vote results announcement, and no presentation or report publication. The content fits the category of Governance Information (CGR), as it details the company's internal governance practices and board election rules.
2025-08-26 Chinese
董事、高级管理人员持股变动管理制度
Board/Management Information Classification · 95% confidence The document is titled as a management system for shareholding changes of directors and senior management of Inner Mongolia Datang Pharmaceutical Co., Ltd. It details rules and procedures regarding the holding and trading of company shares by directors and senior management, including reporting and disclosure obligations. The document includes voting results from a board meeting approving the system and the system's detailed provisions. It is not a financial report, earnings release, or regulatory filing about financial results. It is a governance-related document focused on internal rules about directors' and senior management's shareholding and trading behavior. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or rules related to the company's board or senior management.
2025-08-26 Chinese
董事、高级管理人员离职管理制度
Board/Management Information Classification · 95% confidence The document is a detailed announcement regarding the establishment and approval of an internal management system specifically for the resignation and departure procedures of the company's directors and senior management. It includes procedural rules, obligations, and responsibilities related to board and senior management personnel changes. There is no financial data, earnings information, or report publication mentioned. The content focuses on board and management personnel governance and internal rules. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is 3025 characters, which is consistent with a detailed announcement rather than a brief notice or report publication announcement.
2025-08-26 Chinese
董事、高级管理人员薪酬管理制度
Remuneration Information Classification · 95% confidence The document is a detailed announcement regarding the remuneration management system for the company's directors and senior management. It includes the principles, structure, and rules for compensation, as well as the approval process by the board and shareholders. It is not a financial report, earnings release, or regulatory certification. It specifically focuses on compensation policies and governance related to remuneration. Therefore, it fits the category of Remuneration Information (DEF 14A). The document length is 2278 characters, which is sufficient for a substantive policy document rather than a brief announcement or certification.
2025-08-26 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.